Microscopic colitis and risk of incident rheumatoid arthritis: A nationwide population‐based matched cohort study
暂无分享,去创建一个
[1] J. Ludvigsson,et al. Risk of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis in Patients With Celiac Disease: A Population-Based Cohort Study , 2022, The American journal of gastroenterology.
[2] N. Nyboe Andersen,et al. Autoimmune diseases in microscopic colitis: A Danish nationwide case–control study , 2021, Alimentary pharmacology & therapeutics.
[3] D. Cua,et al. Interleukin-23 in perspective , 2021, Rheumatology.
[4] Kristin E. Burke,et al. Microscopic colitis , 2021, Nature Reviews Disease Primers.
[5] Lang Chen,et al. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis , 2020, BMC Gastroenterology.
[6] Kristin E. Burke,et al. Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study. , 2020, Gastroenterology.
[7] Kristin E. Burke,et al. Obesity and Weight Gain Since Early Adulthood Are Associated With a Lower Risk of Microscopic Colitis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] Samuel E. Jones,et al. Genome-Wide Association Study of Microscopic Colitis in the UK Biobank Confirms Immune-Related Pathogenesis , 2019, Journal of Crohn's & colitis.
[9] J. Ludvigsson,et al. A nationwide cohort study of the incidence of microscopic colitis in Sweden , 2019, Alimentary pharmacology & therapeutics.
[10] M. Neovius,et al. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research , 2019, European Journal of Epidemiology.
[11] J. Ludvigsson,et al. Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden) , 2019, Clinical epidemiology.
[12] J. Ludvigsson,et al. Validating microscopic colitis (MC) in Swedish pathology registers , 2018, Scandinavian journal of gastroenterology.
[13] J. Maul,et al. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy , 2018, Journal of Crohn's & colitis.
[14] P. Ungprasert,et al. Smoking and Risk of Microscopic Colitis: A Systematic Review and Meta-analysis. , 2018, Inflammatory bowel diseases.
[15] D. Jonkers,et al. Early Life Exposure, Lifestyle, and Comorbidity as Risk Factors for Microscopic Colitis: A Case–Control Study , 2017, Inflammatory bowel diseases.
[16] A. Franke,et al. HLA Associations Distinguish Collagenous From Lymphocytic Colitis , 2016, The American Journal of Gastroenterology.
[17] A. Öst,et al. Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis , 2016, Scandinavian journal of gastroenterology.
[18] P. Souverein,et al. High risk of drug‐induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors , 2016, Alimentary pharmacology & therapeutics.
[19] S. Zubair,et al. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. , 2016, Clinica chimica acta; international journal of clinical chemistry.
[20] Zhi-Chao Jin,et al. Body Mass Index and Risk of Rheumatoid Arthritis , 2016, Medicine.
[21] K. Michaëlsson,et al. Registers of the Swedish total population and their use in medical research , 2016, European Journal of Epidemiology.
[22] Gun Peggy Knudsen,et al. Ethical aspects of registry-based research in the Nordic countries , 2015, Clinical epidemiology.
[23] W. Lieb,et al. Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis , 2015, Gut.
[24] J. Askling,et al. Validation of the rheumatoid arthritis diagnosis in the Swedish National patient register: a cohort study from Stockholm County , 2014, BMC Musculoskeletal Disorders.
[25] Se Jin Park,et al. Smoking and Rheumatoid Arthritis , 2014, International journal of molecular sciences.
[26] J. Bohr,et al. Long‐term prognosis of clinical symptoms and health‐related quality of life in microscopic colitis: a case–control study , 2014, Alimentary pharmacology & therapeutics.
[27] P. Gregersen,et al. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. , 2014, American journal of human genetics.
[28] J. Bohr,et al. Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile. , 2013, Molecular immunology.
[29] M. Neovius,et al. Incidence of Rheumatoid Arthritis in Sweden: A Nationwide Population‐Based Assessment of Incidence, Its Determinants, and Treatment Penetration , 2013, Arthritis care & research.
[30] S. Greenland,et al. Ignoring the matching variables in cohort studies – when is it valid and why? , 2013, Statistics in medicine.
[31] B. Ohlsson,et al. Microscopic Colitis is Associated with Several Concomitant Diseases , 2013, Drug target insights.
[32] T. Mcclanahan,et al. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells , 2012, Nature Medicine.
[33] B. Jiang,et al. Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China , 2012, International Journal of Colorectal Disease.
[34] J. Ludvigsson,et al. External review and validation of the Swedish national inpatient register , 2011, BMC public health.
[35] M. Lemire. On the association between rheumatoid arthritis and classical HLA class I and class II alleles predicted from single-nucleotide polymorphism data , 2009, BMC proceedings.
[36] J. Ludvigsson,et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.
[37] J. Ilonen,et al. Human leucocyte antigen and TNF&agr; polymorphism association in microscopic colitis , 2008, European journal of gastroenterology & hepatology.
[38] Anders Sundström,et al. The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months , 2007, Pharmacoepidemiology and drug safety.
[39] L. Truedsson,et al. Analysis of HLA DR, HLA DQ, C4A, FcγRIIa, FcγRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcγRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility , 2004, Arthritis research & therapy.